At OrganoBiotech, our mission is to accelerate drug discovery by combining human-relevant, high-throughput Organ-on-a-Chip technology with the analytical power of machine learning.

OrganoPlatform

Our core technology is the OrganoPlatforms that enable the development of diverse tissue models and assays. The platform supports tissue-specific customization for various biological systems and provides a scalable 3D perfusion tissue culture environment integrated with sensors ideal for high-throughput screening in drug discovery and biomedical research applications.

OrganoAssay

We have also developed a wide range of functional OrganoAssays on the OrganoPlatform to study complex, progressive, and multifactorial diseases. Traditional cell cultures and animal models often fall short in replicating the intricacies of these chronic conditions. Our assays help bridge this gap by leveraging the cellular diversity of human organoids and dynamic control of organ-on-a-chip systems to mimic the native human tissue environment. This enables reliable preclinical testing of drugs, producing data that truly reflect human physiological responses.

OrganoAssay development for modeling pulmonary fibrosis in vitro

OrganoDrug

Leveraging the OrganoPlatform, we have further incorporated machine learning with high-throughput organ-on-a-chip technology to accelerate the development of OrganoDrugs. 

Traditionally, this process from discovery to validation takes extensive time and substantial investment. Our interdisciplinary approach has the potential to achieve these milestones at a faster speed and a reduced cost. 

Complete solution to your 3D tissue and organoid culture needs

We offer a suite of platforms and equipment for 3D tissue and organoid culture. These tools are designed to empower researchers to become effective model developers. If you’ve worked with standard multi-well plates, our systems will feel intuitive—yet far more advanced. 

 

Follow us on Linkedin to see what is new!

We are thrilled about the opportunity to assist Merck 3D Technologies team as they establish their BioFabrication lab! Our co-founder, Dawn Song Yi Lin, has been working closely with Yufang He, Richard Y. Cheng, Narendra Kumar Singh and the team to establish an automated assay workflow with our IFlowPlate and AngioPlate products.

OrganoAssay tissue imaging revealing cellular structure and disease modeling.

Subscribe for Latest updates!

Disclaimer: By subscribing to our emails, you agree to receive periodic communications from us that may include newsletters, updates, and promotions related to our products and services. We are committed to protecting your privacy and will not share your email address with any third parties without your explicit consent.

OrganoBiotech
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.